Benzinga

DECEMBER 12, 2023

Illumina Inc (NASDAQ: ILMN ) reportedly clashed with EU antitrust regulators, alleging an overreach in their investigation into its $7.1 billion acquisition of Grail Inc.

Start-ups 52

Start-ups Equity Marketability 52

Benzinga

JUNE 5, 2023

Get Ready For Apple's WWDC: Software Updates and First New Significant Product In a Decade Apple Inc (NASDAQ: AAPL ) prepares to showcase its VR headset, marking its first significant new product in nearly a decade, on Monday at its annual developer conference. megabanks with substantial trading operations.

Banking 52

Banking Marketability 52

Law 360 M&A

OCTOBER 19, 2023

The Fifth Circuit is asking Illumina Inc. and the Federal Trade Commission how a recent European Union order that Illumina sell off cancer detection company Grail Inc. will impact the FTC's suit challenging the $8 billion purchase.

40

40

Law 360 M&A

MARCH 23, 2023

Federal Trade Commission staffers pushed back against Illumina's contentions that enforcers improperly coordinated with overseas counterparts to try and derail its deal for cancer-testing outfit Grail Inc., saying the company wants to distract from the merits of the commission's challenge.

52

52

Law 360 M&A

AUGUST 11, 2023

Illumina Inc. Securities and Exchange Commission is probing its 2020 reacquisition of Grail for $8 billion, including the conduct and pay of the companies' management. has revealed in a securities filing that the U.S.

40

40

Law 360 M&A

MARCH 15, 2023

Carl Icahn on Wednesday said life sciences company Illumina Inc. is "insulting" the intelligence of its shareholders after the company defended its board and said it would not recommend Icahn's director nominees, the latest volley amid the billionaire's efforts to get Illumina to divest cancer biotech company Grail Inc.

40

40

Law 360 M&A

JUNE 8, 2023

A public interest group urged the Fifth Circuit on Thursday to declare the Federal Trade Commission's structure unconstitutional in a filing supporting Illumina Inc.'s s appeal of the commission's order unwinding the DNA sequencing company's repurchase of cancer testing outfit Grail.

40

40

Law 360 M&A

MARCH 8, 2023

Illumina Inc. says the Federal Trade Commission improperly coordinated with its European counterparts to derail the company's $8 billion reacquisition of cancer-testing outfit Grail Inc. and wants documentation of the enforcers' conversations entered into the FTC's record.

40

40

Law 360 M&A

APRIL 13, 2023

Federal Trade Commission staffers urged the commissioners to ensure Illumina remains separate from Grail Inc. while the company appeals an order to unwind their merger, arguing that keeping their operations apart will spur competition from rival cancer tests.

40

40

Law 360 M&A

APRIL 5, 2023

Federal Trade Commission's order for Illumina Inc. to unwind its reacquisition of Grail, but said he remains concerned about the biotech company's future under CEO Francis deSouza, calling for his "immediate" removal. Activist investor Carl Icahn said Wednesday he is "not surprised" by the U.S.

40

40

Law 360 M&A

NOVEMBER 10, 2022

Biotechnology company Illumina Inc. told members of the Federal Trade Commission in a brief that the agency's in-house judge was right to reject the commission's challenge of its Grail Inc. acquisition, contending that the "lifesaving transaction" will revolutionize cancer screening.

40

40

Benzinga

SEPTEMBER 2, 2022

Illumina Inc (NASDAQ: ILMN ) said it received a favorable initial decision from the judge overseeing the U.S. Federal Trade Commission's challenge to the Grail transaction.

Marketability 52

Marketability 52

Law 360 M&A

SEPTEMBER 6, 2022

The European Union's antitrust watchdog on Tuesday banned DNA sequencing giant Illumina's $8 billion reacquisition of medical testing company Grail Inc., indicating that it will order the companies to unwind the completed deal to protect competition for new cancer screening tests.

40

40

Law 360 M&A

SEPTEMBER 9, 2022

Europe's antitrust authority opened its doors on Friday for businesses to discuss its enhanced powers to block mergers, after it banned DNA sequencing giant Illumina's $8 billion reacquisition of Grail Inc., a medical testing company.

40

40

Law 360 M&A

MARCH 13, 2023

Activist investor Carl Icahn on Monday launched a proxy fight against Illumina Inc.,

40

40

Lighter Capital

AUGUST 17, 2023

For SaaS startups, customer acquisition may seem like the Holy Grail. Getting new customers in the door is vital to building a viable company, after all. No SaaS company is going to survive — much less thrive — without continuous revenue from satisfied customers. Danan Margunson, General Counsel of Tune, Inc.,

Start-ups 95

Start-ups Marketability 95

Reynolds Holding

FEBRUARY 14, 2024

The case involved a derivative lawsuit brought against Illumina by funds controlled by activist investor Carl Icahn in connection with Illumina’s decision to close its acquisition of GRAIL, Inc. despite antitrust regulatory opposition. Neither of these circumstances were present in this case.

45

45

Benzinga

JANUARY 16, 2024

16, 2024 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. 2024 is off to a promising start: - The Company filed its definitive proxy statement for its shareholder meeting scheduled for January 25, 2024, in order to vote on matters related to the combination with GEDi Cube. LOS ANGELES, Jan.

Technology 40

Technology 40

Reynolds Holding

FEBRUARY 13, 2023

The company specifically claimed that it was the ASPCA’s largest corporate donor. In his new book, “Woke Inc.: Yet, it is not easy to see exactly how these goals aid company management itself. Hard-bitten executives and shareholders would hardly allow such self-sabotage in the quest for the earnings-per-share holy grail.

Marketability 59

Marketability 59

Reynolds Holding

FEBRUARY 1, 2023

A wide number of companies also announced separations, divestitures, carve-outs and spin-offs across industries over the course of the year, with over thirty $1 billion-plus divestitures and nearly forty spin-offs announced. billion acquisition by a consortium led by Permira and Hellman & Friedman and Thoma Bravo’s $10.7

Finance 45

Finance Equity Technology Banking 45

Reynolds Holding

OCTOBER 10, 2022

Illumina/GRAIL. Michael Chappell (ALJ) issued a nearly 200-page decision dismissing the FTC’s complaint against Illumina, Inc.’s s vertical acquisition of GRAIL, Inc. GRAIL develops a blood-based multicancer detection (MCED) test that relies upon Illumina’s NGS technology. We discuss the decisions below.

Marketability 56

Marketability Technology 56

Reynolds Holding

JANUARY 21, 2024

As we previously discussed, the new Merger Guidelines demonstrate an increased focus on vertical and conglomerate transactions, competition for labor, potential competition, transactions involving private equity and technology companies, and market trends toward concentration. In Louisiana Children’s Medical Center/HCA Healthcare, Inc.

Marketability 45

Marketability Technology Equity 45